The US beta-glucan market is expected to grow in the coming years due to the increasing demand for beta-glucan supplements and functional foods. The rising awareness of the health benefits of beta-glucan, such as improved immunity and cholesterol management, is driving the market growth. Additionally, the growing trend of clean label and natural products is also contributing to the market expansion.
The global beta-glucan market is estimated to be worth USD 1,200 Mn in the year 2021 and is expected to grow to a value of USD 2,108.8 Mn by the year 2032, with a CAGR (Compound annual growth rate) of 5.8 % throughout the assessment period.
Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-489
On the basis of functionality type, the market has been segmented into soluble beta-glucan and insoluble beta-glucan. The soluble beta-glucan segment accounted for 63.1% share of the global beta-glucan market in 2014, and is expected to register healthy CAGR of 7.1% over the forecast period. Insoluble beta-glucan segment accounted for 36.8% share of the global beta-glucan market in 2014, and is expected to register CAGR of 6.8% over the forecast period.
On the basis of source type, the market has been segmented into cereal, yeast and others (mushroom). The cereal segment accounted for 45.2% share of the global beta-glucan market in 2014, and is expected to register healthy CAGR similar to that projected for the global beta-glucan market over the forecast period.
The cereal segment is sub-segmented into oats and barley. Revenue contribution of oats was 69.3% in 2014 and is projected to decrease to 68.8% by 2025, gaining 40 basis point share (BPS) and registering a CAGR of 7.1%. Furthermore, revenue contribution of barley was 30.7% in 2014, and is projected to increase to 31.2% by 2025, gaining 50 BPS and registering a CAGR of 7.3%. Yeast segment is expected to register CAGR of 6.9% between 2015 and 2025 and others (mushroom) segment is expected to register a CAGR of 6.6%, losing 30 BPS.
On the basis of application type, the market has been segmented into food and beverage, bakery products, health and dietary supplements, dairy and frozen products, cosmetics and personal care and others (animal feed). The health and dietary supplement segment accounted for 33.7% share of the global beta-glucan market in 2014, and is expected to register healthy CAGR of 7.1% over the forecast period.
Growth of the global beta-glucan market is mainly driven by rising health awareness and new functional food product launches, growing disposable income, increasing promotional activities and growing technological advancements in beta-glucan extraction techniques. Other trends driving market growth include expansion and product enhancement strategies by various players in the market.
This report covers trends driving each segment and respective sub-segments and offers analysis and insights of the potential of the beta-glucan market in specific regions. Western Europe dominated the beta-glucan market with over 36.1% market share in 2014, and is anticipated to remain dominant by 2025. North America and Asia Pacific Excluding Japan collectively accounted for over 40% of the total beta-glucan market share in 2014. Among all the regions, Western Europe is anticipated to register the highest CAGR between 2015 and 2025, followed by North America due to increasing health concerns and government approvals in these region.
Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-489
Key players in the global beta-glucan market include Associated British Foods Plc., Biothera the Immune Health Company, Ceapro Inc., and Koninklijke DSM N.V. Major participants such as Biothera Inc. and Tate and Lyle focus on research and development activities to enhance product portfolio in order to sustain in the competitive market. In addition, these key players focus on expanding exclusive functional food product portfolio through acquisition of various raw materials and end-product manufacturing companies with the objective to enhance market position.
In early 2015 for instance, First Endurance launched multi-vitamin product MuliV-Pro using beta-glucan derived from Wellume Yeast, a product from Biothera the Immune Health Company. This product helps to improve athlete’s performance by supporting immune health.
About FMI
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers-
Dubai
United Arab Emirates
For Sales Queries: sales@futuremarketinsights.com
Browse All Report: https://www.futuremarketinsights.com/reports
